Alkermes ALKS
NASDAQ ALKS
$45.38 -0.12 (-0.25%)
As of: Sep 9, 2026 · 3:27 PM EDT

Alkermes (ALKS) Net Income (2010 - 2026)

Alkermes' (ALKS) quarterly Net Income came in at $524000.0 in Q2 2026, down 99.4% year-over-year from $87.1 million in Q2 2025, and up 100.79% quarter-over-quarter from -$66.5 million in Q1 2026.

Analysis

Alkermes (ALKS) Net Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Net Income for 17 consecutive years, with $524000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Income fell 99.4% year-over-year to $524000.0 in Q2 2026; TTM through Jun 2026 was $66.1 million, a 81.04% decrease from a year earlier, with the FY2025 full-year figure at $241.7 million, down 34.03% from the prior year.
  • Net Income was $524000.0 for Q2 2026 at Alkermes, up from -$66.5 million in the prior quarter.
  • Over five years, Net Income peaked at $237.0 million in Q2 2023 and troughed at -$66.5 million in Q1 2026.
  • A 5-year average of $47.4 million and a median of $47.8 million in 2023 frame the typical range for Net Income.
  • Across the five-year window, Net Income slumped 1374.79% in 2022 and soared 886.52% in 2023, its largest moves.
  • Over 5 years, Net Income stood at $87.7 million in 2022, then surged by 36.46% to $119.7 million in 2023, then increased by 22.73% to $146.9 million in 2024, then slumped by 66.38% to $49.4 million in 2025, then tumbled by 98.94% to $524000.0 in 2026.
  • The last three Net Income figures came in at $524000.0 (Q2 2026), -$66.5 million (Q1 2026), and $49.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 645.93 Bn 625.17 Bn 17.26 Bn 5.53 Bn
2 AbbVie 443.06 Bn 436.49 Bn 12.70 Bn 3.62 Bn
3 Merck 365.76 Bn 358.62 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.47 Bn 258.78 Bn 11.24 Bn 5.28 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.36 Bn 44.98 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 43.97 Bn 43.97 Bn - -644.37 Mn
8 Incyte 25.42 Bn 20.88 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.52 Bn 18.86 Bn 683.80 Mn 333.00 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn 524,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 524,000.00
Mar 31, 2026 -66.53 Mn
Dec 31, 2025 49.39 Mn
Sep 30, 2025 82.75 Mn
Jun 30, 2025 87.10 Mn
Mar 31, 2025 22.46 Mn
Dec 31, 2024 146.90 Mn
Sep 30, 2024 92.31 Mn
Jun 30, 2024 90.71 Mn
Mar 31, 2024 36.40 Mn
Dec 31, 2023 119.70 Mn
Sep 30, 2023 46.16 Mn
Jun 30, 2023 237.03 Mn
Mar 31, 2023 -48.57 Mn
Dec 31, 2022 87.72 Mn
Sep 30, 2022 -63.97 Mn
Jun 30, 2022 -30.14 Mn
Mar 31, 2022 -35.90 Mn
Dec 31, 2021 125.44 Mn
Sep 30, 2021 -28.99 Mn